Delivery Order SPE2DR25D2005-SPE2DR26FE9G9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,933.79 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (30 unit dose packages) with a completion date of November 18, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,118.25 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (undivided 30-count packaging) with an ultimate completion date of November 25, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Micardis HCT 80-25 mg tablets (30-unit dose packages) with a ceiling value of $2,308.79. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,163.02 to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 40-12.5 mg tablets in unit dose packaging (30 count) on September 2, 2025, with completion expected by September 3, 2025. This contract was awarded on a non-competitive, firm fixed-price basis and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30 count) with a contract value of $4,957.67 and an ultimate completion date of October 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed under a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $27,546.64 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Micardis HCT 80-25 mg tablets (unit dose, 30-count packages). This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,093.19 to supply Micardis HCT 80-25 mg tablets (undivided 30 count) with a firm fixed price structure. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of December 5, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,044.82 to supply Micardis HCT 80-25 mg tablet unit dose packages (30 count) with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Micardis HCT 40-12.5 mg tablets (unit dose, 30 count) with a contract value of $3,124.61. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.12 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (30-count unit dose packaging) with a firm fixed price and completion deadline of December 18, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the pharmaceutical products will be supplied from. The delivery order represents a child contract under...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE9G9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,667.72 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging of 30 units. This non-competitive delivery order, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters, where AmerisourceBergen operates as a major pharmaceutical distributor supporting federal medical procurement needs. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As a prime vendor for DLA's Medical Supply Chain, AmerisourceBergen continues to fulfill critical medication requirements for the Defense Health Agency and other government healthcare systems through this strategic contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/18/25 |